Henrik Harling

New data from 2cureX IndiTreat at ASCO

June's highly anticipated virtual ASCO conference will highlight new data from 2cureX clinical partner, Vejle...

Strong Q3 for 2cureX culminates in IndiTreat launch

Last week, 2cureX's Q3 report was released and it...

2cureX begins its first clinical partnership in Sweden

This week, 2cureX announced that it is launching a...

Steady progress for 2cureX in 2019

For Danish 2cureX, 2019 has meant a steady...

2cureX promises more in 2019

During the autumn, 2cureX has worked intensively with Early...

2cureX tops off eventful first half of 2019 with addition of expert clinician as Chief Medical Officer

2019 has seen 2cureX reaping the benefits of...

2cureX enrolls first patients in pancreatic cancer clinical trials

The burden of pancreatic cancer is on the...

Clinical expert: “IndiTreat could be an important piece of the cancer puzzle”

Tumor resistance is one of the largest and most...